Detection of IκB mRNA in HRS Cells and Reactive Lymphoid Cells in 20 Cases of Classical HD by Radioactive In-Situ Hybridization
Case . | Type . | Tumor Cells . | Bystander Cells . | ||
---|---|---|---|---|---|
No. of Positive Cells (%) . | Intensity . | Proportion of Positive Cells (%) . | Intensity . | ||
1 | NS | 80-90 | ++ | <20 | + |
2 | NS | 60-70 | ++ | <10 | + |
3 | MC | 60 | +++ | <3 | + |
4 | MC | 70-80 | ++ | <20 | ++ |
5 | MC | 30 | ++ | <3 | + |
6 | MC | 40 | ++ | <10 | + |
7 | MC | 50 | ++ | <3 | + |
8 | MC | <10 | + | <20 | + |
9 | MC | 10 | + | <3 | + |
10 | MC | 80 | +++ | <10 | + |
11 | MC | 90 | +++ | <20 | ++ |
12 | NS | 95 | ++ | <20 | + |
13 | NS | 90 | +++ | <20 | + |
14 | MC | 80-90 | ++ | <10 | ++ |
15 | NS | 90 | +++ | <20 | ++ |
16 | NS | 60 | +++ | <10 | + |
17 | NS | 90 | +++ | <3 | + |
18 | NS | 60 | ++ | <20 | + |
19 | NS | 10 | + | <3 | + |
20 | NS | 30 | ++ | <10 | ++ |
Case . | Type . | Tumor Cells . | Bystander Cells . | ||
---|---|---|---|---|---|
No. of Positive Cells (%) . | Intensity . | Proportion of Positive Cells (%) . | Intensity . | ||
1 | NS | 80-90 | ++ | <20 | + |
2 | NS | 60-70 | ++ | <10 | + |
3 | MC | 60 | +++ | <3 | + |
4 | MC | 70-80 | ++ | <20 | ++ |
5 | MC | 30 | ++ | <3 | + |
6 | MC | 40 | ++ | <10 | + |
7 | MC | 50 | ++ | <3 | + |
8 | MC | <10 | + | <20 | + |
9 | MC | 10 | + | <3 | + |
10 | MC | 80 | +++ | <10 | + |
11 | MC | 90 | +++ | <20 | ++ |
12 | NS | 95 | ++ | <20 | + |
13 | NS | 90 | +++ | <20 | + |
14 | MC | 80-90 | ++ | <10 | ++ |
15 | NS | 90 | +++ | <20 | ++ |
16 | NS | 60 | +++ | <10 | + |
17 | NS | 90 | +++ | <3 | + |
18 | NS | 60 | ++ | <20 | + |
19 | NS | 10 | + | <3 | + |
20 | NS | 30 | ++ | <10 | ++ |
Abbreviations: NS, nodular sclerosing; MC, mixed cellularity; +, weak; ++, moderate; +++, strong.